Abbott Laboratories And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – BlackRock Income Trust (BKT), Putnam Premier Income Trust (PPT), AudioCodes Ltd. (AUDC) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. BlackRock Income Trust (BKT)

294.86% Payout Ratio

BlackRock Income Trust, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the fixed income markets of the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in securities such as U.S. government sponsored agency securities, non-agency mortgage-backed securities, asset-backed securities, and U.S. treasury obligations. The fund invests its assets in securities that are issued or guaranteed by the US government or one of its agencies or instrumentalities or rated at the time of investment either AAA by S&P or Aaa by Moody's. BlackRock Income Trust, Inc. was formed on July 22, 1988 and is domiciled in the United States.

Earnings Per Share

As for profitability, BlackRock Income Trust has a trailing twelve months EPS of $-0.75.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.54%.

2. Putnam Premier Income Trust (PPT)

204.71% Payout Ratio

Putnam Premier Income Trust is a closed ended fixed income mutual fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public fixed income markets across the globe. The fund primarily invests in U.S. high-grade and high-yield bonds with an average credit quality of BBB by S&P Corporation. It benchmarks the performance of its portfolio against the Barclays Capital Government Bond Index. Putnam Premier Income Trust was formed on February 29, 1988 and is domiciled in the United States.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.25%.

3. AudioCodes Ltd. (AUDC)

92.31% Payout Ratio

AudioCodes Ltd. provides advanced communications software, products, and productivity solutions for the digital workplace. The company offers solutions, products, and services for unified communications, contact centers, VoiceAI business line, and service provider business. Its products include session border controllers, life cycle management solutions, VoIP network routing solutions, media gateways and servers, multi-service business routers, IP phones solutions, and value-added applications, as well as professional services. The company also offers One Voice Operations Center, a voice network management solution; Device Manager for administering business phones and meeting room solutions; AudioCodes Routing Manager for handling call routing in VoIP networks; and User Management Pack 365 simplifies user lifecycle and identity management across Microsoft Teams and Skype for Business deployments. In addition, it provides AudioCodes Live for Microsoft Teams, a portfolio of managed services for simplifying Teams adoption; appliances for Microsoft Skype/Teams for Business such as survivable branch appliances, CCE, and CloudBond 365; and a range of value-added voice applications comprising SmartTAP, Voca, VoiceAI Connect, and Meeting Insights. Further, the company offers managed services; and AudioCodes Live Cloud, a Microsoft Teams software as a service solution that enables service providers to offer their business customers a seamless migration to Microsoft Teams. It primarily markets and sells its products through a direct sales force and sales representatives to original equipment manufacturers, network equipment providers, and systems integrators and distributors in the telecommunications and networking industries. The company primarily operates in the Americas, Europe, the Far East, and Israel. AudioCodes Ltd. was incorporated in 1992 and is headquartered in Lod, Israel.

Earnings Per Share

As for profitability, AudioCodes Ltd. has a trailing twelve months EPS of $0.39.

PE Ratio

AudioCodes Ltd. has a trailing twelve months price to earnings ratio of 30.9. Meaning, the purchaser of the share is investing $30.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.08%.

Volume

Today’s last reported volume for AudioCodes Ltd. is 60085 which is 52.89% below its average volume of 127549.

Moving Average

AudioCodes Ltd.’s value is above its 50-day moving average of $11.59 and way higher than its 200-day moving average of $10.20.

Revenue Growth

Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 251.48M for the twelve trailing months.

Yearly Top and Bottom Value

AudioCodes Ltd.’s stock is valued at $12.05 at 01:23 EST, way below its 52-week high of $20.60 and way above its 52-week low of $7.14.

4. Magic Software Enterprises Ltd. (MGIC)

81.43% Payout Ratio

Magic Software Enterprises Ltd. provides proprietary application development, business process integration, vertical software solutions, and information technologies (IT) outsourcing software services in Israel and internationally. The company's Software Services segment develops, markets, sells, and supports application platform, software applications, and business and process integration solutions and related services. Its IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, and supplemental outsourcing services. The company offers proprietary application platforms, such as Magic xpa for developing and deploying business applications; AppBuilder for building, deploying, and maintaining high-end and mainframe-grade business applications; Magic xpi for application integration; Magic xpc, a hybrid integration platform as a service; Magic SmartUX, a mobile development application platform; and FactoryEye for virtualization of production data. It also provides vertical software solutions comprising Clicks, a software solution for healthcare providers; Leap, a software solution for business support systems; Hermes Solution, a packaged software solution for managing air cargo ground handling; HR Pulse, a customized single-tenant software as a service tool; and MBS Solution, a proprietary system for managing TV broadcast management. In addition, the company provides software maintenance, support, training, and consulting services. It serves oil and gas, telecommunications, financial, healthcare, and industrial sectors; and public institutions and international agencies. The company was formerly known as Mashov Software Export (1983) Ltd. and changed its name to Magic Software Enterprises Ltd. in 1991. Magic Software Enterprises Ltd. was incorporated in 1983 and is headquartered in Or Yehuda, Israel.

Earnings Per Share

As for profitability, Magic Software Enterprises Ltd. has a trailing twelve months EPS of $0.77.

PE Ratio

Magic Software Enterprises Ltd. has a trailing twelve months price to earnings ratio of 12.97. Meaning, the purchaser of the share is investing $12.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.8%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10.1%, now sitting on 556.65M for the twelve trailing months.

5. Abbott Laboratories (ABT)

62.58% Payout Ratio

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Earnings Per Share

As for profitability, Abbott Laboratories has a trailing twelve months EPS of $3.26.

PE Ratio

Abbott Laboratories has a trailing twelve months price to earnings ratio of 34.37. Meaning, the purchaser of the share is investing $34.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.34%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Abbott Laboratories’s EBITDA is 66.43.

Sales Growth

Abbott Laboratories’s sales growth is 10.9% for the current quarter and 8.1% for the next.

Yearly Top and Bottom Value

Abbott Laboratories’s stock is valued at $112.04 at 01:23 EST, below its 52-week high of $115.83 and way above its 52-week low of $89.67.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of $1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Leave a Reply

Your email address will not be published. Required fields are marked *